Shibaura Institute Creates 12 Vitamin K Analogues, Tripling Neuron-Growth Activity
Updated
Updated · ScienceDaily · May 27
Shibaura Institute Creates 12 Vitamin K Analogues, Tripling Neuron-Growth Activity
1 articles · Updated · ScienceDaily · May 27
A Shibaura Institute team developed 12 vitamin K-based compounds, with a lead candidate driving neural progenitor cells to become neurons at about three times the rate of natural vitamin K.
The strongest analogue fused vitamin K with retinoic-acid elements and a methyl ester side chain, preserving activity through both vitamin K and vitamin A signaling pathways in mouse neural cells.
Gene-expression analysis pointed to mGluR1 as a key mediator, and docking studies suggested the lead compound bound that receptor more strongly than MK-4, the natural active form of vitamin K.
Mouse tests showed the compound crossed the blood-brain barrier, had stable pharmacokinetics, and generated higher brain MK-4 levels than control compounds.
The findings, published in ACS Chemical Neuroscience, remain limited to cell and mouse studies but suggest a possible regenerative route for Alzheimer’s, Parkinson’s and Huntington’s beyond symptom control.
After a year of promising mouse data, when will this 'supercharged' vitamin K compound begin human trials for Alzheimer's?
How does this vitamin K breakthrough compare to gene therapies also racing to conquer the brain's defenses?
Could this 'supercharged' vitamin's power to create new neurons also carry unforeseen risks for the human brain?
Breakthrough Vitamin K Analogues Triple Neuron Growth and Offer Hope for Reversing Neurodegenerative Diseases
Overview
Recent groundbreaking research has led to the engineering of novel vitamin K analogues with significantly enhanced abilities to promote neuron growth and provide neuroprotection. Scientists have unveiled these new compounds as a promising direction for neurodegenerative disease treatment in 2026. The crucial neuroprotective effects of vitamin K and its analogues have paved the way for innovative therapies that go beyond symptom management. These novel compounds actively encourage neural progenitor cells to mature into functional neurons, offering a potentially transformative approach that aims to slow or even reverse the progression of diseases like Alzheimer's, marking a new era for brain health.